Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Musculoskeletal | Family Medicine
Disease Category: Parkinson's Disease
Location: United States, IL
Clinical Trial Details
Research Study Summary
A multicenter, double blind, randomized, parallel group, placebo controlled study to assess the clinical effect of Droxidopa in the treatment of symptomatic neurogenic orthostatis hypotension in patients with Parkinson's Disease
The purpose of this research study is to determine whether Droxidopa can relieve the symptoms of NOH and whether it causes any side effects in people with symptomatic NOH. Droxidopa is a drug that is changed in the body to a chemical called norepinephrine. Norepinephrine is a chemical in your body that is used by your body’s nervous system to signal nerves that control blood pressure. The study drug that you will take if you are in this study is a capsule that contains either Droxidopa or placebo (an identical-looking pill that does not contain any active drug; a placebo is sometimes called a "sugar pill"). The reason for having people take placebo in this study is to see if taking droxidopa is better than taking placebo.
Please contact Alexian Brothers for more information on participation.
To Learn more
Both Male and Female
Date Last Changed:
July 22, 2013
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.